Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
The Sounds of Science podcast is brought to you by GEN. Listen as members of the editorial team—Editor-in-Chief John Sterling, Technical Editor Jeff Buguliskis, and Senior News Editor Alex Philippidis—showcase innovative research, new initiatives, and important policy by interviewing thought-leaders, eminent life-science researchers, and company leaders. These short, but informative podcasts will keep you up-to-date with the latest and most important life science advances.
Benjamin Corb, public affairs director for the American Society for Biochemistry and Molecular Biology (ASBMB), discusses what the biomedical research community can expect from the incoming administration of Donald J. Trump.
The next generation of toys could be controlled by the power of the mind, thanks to researchers at the University of Warwick who have recently developed electronic devices to be activated using electrical impulses from brain waves, by connecting our thoughts to computerized systems.
A new survey led by researchers at Stanford University School of Medicine asked a representative group of adults 65 and older, how willing they would be to learn about their possible cognitive decline. Listen now for more details!
Jay Jackson, manager with Avalere Health, discusses the 21st Century Cures Act, which recently passed both houses of Congress by overwhelming majorities. The measure has long been championed by supporters as a vehicle for speeding up approval of new drugs and maintaining U.S. leadership in research. Critics say the bill does too much for big pharma and not enough for patients seeking relief from rising drug prices.
Scientists in Ireland have solved a mystery regarding the cause of especially smelly camel urine. Their research has implications for the millions of people affected by African parasites called trypanosomes, which frequently cause death from sleeping sickness.
David G. Maloney, M.D., Ph.D., of the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance, discusses the new Bezos Family Immunotherapy Clinic, a first-of-its-kind facility focused on providing cancer immunotherapies to patients.
Findings from a new retrospective study has found that active marijuana use could increase the risk for developing a rare cardiovascular event.
A new computer analysis from investigators at the MD Anderson Cancer Center suggests that traces of long-lost human cousins may be buried in modern people’s DNA.
Mary Woolley, President of Research!America, which advocates for medical and health research funding, discusses key issues in research that the next president is likely to confront. How can researchers keep those issues on the national agenda no matter who wins on Election Day?
A new study from investigators at The Ohio State University entitled “Gut dysbiosis impairs recovery after spinal cord injury,” describes the impact the gut microbiome has on spinal cord injury and how probiotics could help speed recovery.
One area where biopharma employment has been increasing is in regulatory affairs and compliance.
Quadruple helices appear to have role in switching genes on or off.
Yale University researchers have uncovered the intriguing mechanisms that underlie common sickness behaviors.
Interview with Jon Soderstrom, Ph.D., managing director of the office of cooperative research at Yale University and moderator of the BIO tech transfer session, and Atul Saran, senior vp of corporate development and ventures at MedImmune
Interview with Jim Vaught, Ph.D., Deputy Director, NCI Office of Biorepositories and Biospecimen Research
Alan Russell, Ph.D., Editor in Chief
E. Morrey Atkinson, Ph.D., CSO, VP of R&D, Cook Pharmica
Jeffrey Karp, Ph.D., Co-Director, Center for Regenerative Therapeutics; Associate Bioengineer, Brigham and Women’s Hospital; and Assistant Professor, Harvard Medical School
Gholson Lyon, M.D., Ph.D., Senior Scientist, Principal Investigator, Center for Applied Genomics, The Children’s Hospital of Philadelphia
Benjamin Schuler, Ph.D., Professor of Biochemistry, University of Zurich